SERVICE & PRODUCT

Cancer Drug Monitoring

> SERVICE & PRODUCT > Cancer Drug Monitoring

Liquid biopsy evaluates the therapeutic response of the anticancer drug and predicts a relapse of cancer.

Comparison of survival curves using Kaplan-Meier Survival Analysis in presence or absence of CTCs

Progression-free survival

Overall Survival

  • Throughout cancer treatment, a CTC-based liquid biopsy is performed with periodically withdrawn blood from cancer patients.
  • Analysis of CTCs uncovers the response and prognosis of a patient to the cancer treatment.